6E: 3D and Nano Biomaterials RAPID FIRE

Timeslot: Friday, April 21, 2023 - 11:30am to 12:30pm
Room: Coral 3-4

About

This session covers the development of three-dimensional (3D) biomaterial platforms, such as hydrogels, bioprinted materials, electrospun scaffolds as well as nanomaterials for tissue engineering and drug delivery applications. It focuses on in vitro models for the study of tissue physiology and disease pathology for a variety of diseases such as glaucoma, cancer, and lupus. On the drug delivery side, it explores the development of new nanodevices, such as bone-targeted nanoparticles, vaccine gene delivery platforms, or cancer therapies.

  • 11:30 AM 301. Modeling Age in Macrophage-Endothelial Interactions and Therapeutic Interventions in a 3D PEG Hydrogel. Justin Silberman, Erika Moore, PhD, University of Florida, Gainesville, FL, USA.

  • 11:35 AM 302. A 3D Platform to Study Monocyte Activation in Systemic Lupus Erythematosus. Holly Ryan, Mark Segal, MD, PhD, Erika Moore, University of Florida, Gainesville, FL, USA.

  • 11:40 AM 303. A 3D Bioprinted Hydrogel-Based Microfluidic Device for Anti-Cancer Drug Screening. Amir K. Miri, Anant Bhusal, New Jersey Institute of Technology, Newark, NJ, USA, Rowan University, Glassboro, NJ, USA.

  • 11:45 AM 304. 3D Printed Gelatin Methacrylate Models for Normal and Glaucomatous Trabecular Meshwork Studies. Bikram Adhikari, Mina Pantcheva, MD, Melissa Krebs, PhD, Colorado School of Mines, Golden, CO, USA, University of Colorado School of Medicine, Aurora, CO, USA.

  • 11:50 AM 305. Desmoplastic Pancreatic Adenocarcinoma Mimicking Hydrogels for Modelling 3D Cancer Spheroids. Menekse Ermis, MD, PhD, Natashya Falcone, PhD, Natan Barros, PhD, Marvin Mecwan, PhD, Reihaneh Haghniaz, PhD, Auveen Choroomi, Mahsa Monirizad, Yangzhi Zhu, PhD, Ali Khademhosseini, PhD, Junmin Lee, PhD, Han-Jun Kim, Terasaki Institute for Biomedical Innovation, Los Angeles, CA, USA, 2Pohang University of Science and Technology (POSTECH), Pohang, Kyungbuk, Republic of Korea.

  • 12:00 PM 306. Development of an Injectable Upconversion Nanoparticle conjugated Doxorubicin Theranostics Electrospun Nanostructure for Breast Cancer. Amreen Khan, Mayuri Gandhi, Jayesh Bellare, Professor, Rohit Srivastava, Indian Institute of Technology Bombay India, Mumbai, India.

  • 12:05 PM 307. Bone-Targeted Nanoparticles Modulate Macrophage-Mediated Fracture Healing. Baixue (Dorothy) Xiao, Danielle Benoit, Marian Ackun-Farmmer, Yuchen Wang, University of Rochester, Rochester, NY, USA, University of Oregon, Eugene, OR, USA.

  • 12:10 PM 308. Effect of Lipid Saturation and Cholesterol Concentration on Liposome Interaction with Fungal and Mammalian Cells. Veronica LaMastro, Kayla Campbell, PhD, Peter Gonzalez, Tobias Meng-Saccoccio, Anita Shukla, PhD, Brown University, Providence, RI, USA.

  • 12:15 PM 309. Lipid-Polymer Hybrid “Particle-in-Particle” Nanostructure Gene Delivery Platform Explored for Lyophilizable DNA and mRNA COVID-19 Vaccines. Zhongyu Li, Xiaoyang Xu, New Jersery Institute of Technology, Newark, NJ, USA.

  • 12:20 PM 310. Investigation of the Protein Corona’s Impact on Nanoliposome Drug Delivery Systems in Cancer Cells Using QCM-D. Nicholas Van Der Sanden, Maryam Tabrizian, PhD, McGill University, Montreal, QC, Canada.